Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2025-12-31
• Last 15 days FTD volume: NZ$0.13 M
• Last 3 months FTD volume: NZ$0.79 M
• Last 12 months FTD volume: NZ$4.53 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	NZ$36.84 M	NZ$0.14 B	🇺🇸 USA
SIGA Technologies SIGA	NZ$0.11 M	NZ$1.17 M	🇺🇸 USA
GlaxoSmithKline GSK	NZ$49.05 M	NZ$0.36 B	🇬🇧 UK
Celldex Therapeutics CLDX	NZ$6.56 M	NZ$11.6 M	🇺🇸 USA
Pfizer PFE	NZ$55.69 M	NZ$0.12 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	NZ$53.13 M	NZ$87.53 M	🇮🇱 Israel
Soligenix SNGX	NZ$0.86 M	NZ$14.12 M	🇺🇸 USA